Latest RVMD Analyst Ratings & Recommendations
Recent analyst recommendations with rating changes and price target updates (last 90 days)
| Date | Analyst | Firm | Action | Rating | Price Target |
|---|---|---|---|---|---|
| Michael Yee | UBS | Reiterates | Buy | $265.00 | |
| Sean Laaman | Morgan Stanley | Maintains | Buy | $255.00 | |
| Tyler Van Buren | TD Cowen | Reiterates | Buy | $250.00 | |
| Brian Cheng | JP Morgan | Maintains | Buy | - | |
| Gregory Renza | Truist | Maintains | Buy | $240.00 → $241.00 +1.00 (+0.4%) | |
| Alec Stranahan | BofA Securities | Maintains | Buy | $264.00 | |
| Michael Schmidt | Guggenheim | Maintains | Buy | $275.00 | |
| Sharon Zackfia | William Blair | Initiates | Buy | $226.00 | |
| Ami Fadia | Needham | Reiterates | Buy | $275.00 | |
| Leonid Timashev | RBC Capital | Maintains | Buy | $259.00 → $260.00 +1.00 (+0.4%) | |
| Michael Schmidt | Guggenheim | Maintains | Buy | $275.00 | |
| Alec Stranahan | BofA Securities | Maintains | Buy | $265.00 → $264.00 −1.00 (−0.4%) | |
| Laura Prendergast | Stifel Nicolaus | Maintains | Buy | - | |
| Tyler Van Buren | TD Cowen | Maintains | Buy | - | |
| Leonid Timashev | RBC Capital | Maintains | Buy | $251.00 → $259.00 +8.00 (+3.2%) | |
| Gregory Renza | Truist | Maintains | Buy | $239.00 → $240.00 +1.00 (+0.4%) | |
| Charles Zhu | LifeSci Capital | Maintains | Buy | $315.00 | |
| Leah R. Cann | Brookline Capital | Initiates | Buy | $318.00 | |
| Jeffrey Walch | Bernstein | Maintains | Hold | $179.00 | |
| Jeffrey Walch | Bernstein | Maintains | Hold | $179.00 | |
| Andrea Newkirk | Goldman Sachs | Initiates | Buy | $267.00 | |
| Alec Stranahan | BofA Securities | Reiterates | Buy | $225.00 → $265.00 +40.00 (+17.8%) | |
| Leonid Timashev | RBC Capital | Maintains | Buy | $251.00 | |
| Laura Prendergast | Stifel Nicolaus | Maintains | Buy | $215.00 → $230.00 +15.00 (+7.0%) | |
| Sean Laaman | Morgan Stanley | Initiates | Buy | $255.00 | |
| Gregory Renza | Truist | Maintains | Buy | - | |
| Faisal Khurshid | Jefferies | Maintains | Buy | $270.00 | |
| Brian Cheng | JP Morgan | Maintains | Buy | $246.00 | |
| Ami Fadia | Needham | Reiterates | Buy | $240.00 → $275.00 +35.00 (+14.6%) | |
| Michael Yee | UBS | Maintains | Buy | $220.00 → $265.00 +45.00 (+20.4%) | |
| Robert Driscoll | Wedbush | Maintains | Buy | $201.00 → $225.00 +24.00 (+11.9%) | |
| Michael Schmidt | Guggenheim | Maintains | Buy | $240.00 → $275.00 +35.00 (+14.6%) | |
| Robert Burns | HC Wainwright | Reiterates | Buy | $195.00 → $280.00 +85.00 (+43.6%) | |
| Eva Fortea Verdejo | Wells Fargo | Initiates Coverage | Buy | $240.00 | |
| Jay Olson | Oppenheimer | Maintains | Buy | $230.00 → $260.00 +30.00 (+13.0%) | |
| Sean McCutcheon | Raymond James | Maintains | Buy | $230.00 → $248.00 +18.00 (+7.8%) | |
| Zacks Equity Research | Zacks Equity Research | Initiates Coverage | Sell | - | |
| Cory Kasimov | Evercore ISI Group | Maintains | Buy | $230.00 → $320.00 +90.00 (+39.1%) | |
| Marc Frahm | TD Cowen | Reiterates | Buy | - | |
| Kalpit Patel | Wolfe Research | Maintains | Buy | $165.00 → $220.00 +55.00 (+33.3%) | |
| Kelsey Goodwin | Piper Sandler | Maintains | Buy | $172.00 → $210.00 +38.00 (+22.1%) |
